Alethia Biotherapeutics Announces the Issuance of a United States Patent for ... Marketwire (press release) MONTREAL, QUEBEC--(Marketwired - May 16, 2013) - Alethia Biotherapeutics Inc., a privately held biotechnology company focusing on the development of therapeutic monoclonal antibodies, announced today that the Company has been granted United ... |
